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Transcriptional control of circadian metabolic rhythms in the liver
S. Li & J. D. Lin
Life Sciences Institute and Department of Cell & Developmental Biology, University of Michigan, Ann Arbor, MI, USA
Diurnal metabolic rhythms add an important temporal dimension to metabolic homeostasis in mammals. Although it remains a challenge to untangle the
intricate networks of crosstalk among the body clock, nutrient signalling and tissue metabolism, there is little doubt that the rhythmic nature of nutrient
and energy metabolism is a central aspect of metabolic physiology. Disruption of the synchrony between clock and metabolism has been causally linked
to diverse pathophysiological states. As such, restoring the rhythmicity of body physiology and therapeutic targeting directed at specific time windows
during the day may have important implications in human health and medicine. In this review, we summarize recent findings on the integration of
hepatic glucose metabolism and the body clock through a regulatory network centred on the PPAR𝛾 coactivator 1 (PGC-1) transcriptional coactivators.
In addition, we discuss the transcriptional mechanisms underlying circadian control of the autophagy gene programme and autophagy in the liver.
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Circadian Clock and Energy Metabolism
The body clock controls many aspects of mammalian phys-
iology, including the sleep–wake cycle, locomotor activity,
hormone release andmetabolism.These biological rhythms are
entrained by the light–dark (LD) and feeding cycles. In mam-
mals, themaster clock is located in the suprachiasmatic nucleus
(SCN) of the ventral hypothalamus. Light resets the phase of
the central pacemaker, which in turn synchronizes clocks in
peripheral tissues. Remarkably, peripheral oscillators can be
uncoupled from the central clock in response to restricted feed-
ing [1–3], underscoring the importance of nutritional signals
in circadian timing in the peripheral tissues. Clock oscillators
regulate diverse organismal functions, but also operate in a
cell-autonomous manner. Tissue explants can maintain robust
rhythmic patterns of gene expression over a period of days
to weeks in culture dishes [4]. Further, individual fibroblasts
harbour intrinsic rhythms that undergo synchronization in
response to a variety of stimuli, such as brief serum shock and
exposure to glucocorticoids or forskolin [5,6].
Nutrient and energy metabolism is tightly integrated with
the circadian timing system in mammals [7–9]. The con-
centrations of plasma metabolites such as amino acids and
lipids, and circulating hormones, exhibit varying degrees of
circadian rhythms. Recent metabolomic profiling of plasma
in mice and humans revealed extensive diurnal oscillation
[10–12], probably as a result of a combination of feeding
cycles and endogenous metabolic rhythms. This daily ebb
and flow of metabolites is accompanied by cyclic activation of
major metabolic pathways in the liver, including gluconeoge-
nesis, de novo lipogenesis, lipoprotein secretion, cholesterol
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biosynthesis and xenobiotic detoxification. At the molecular
level, transcriptional profiling using microarray and RNA
sequencing has revealed extensive rhythmic expression of
hepatic genes throughout the LD cycles [13–17]. A signifi-
cant number of these cycling genes encode enzymes involved
in glucose, lipid, amino acid and mitochondrial oxidative
metabolism. As such, many metabolic processes are restricted
not only to certain tissues in the body but also during specific
time periods during the day.
“The integration of body clock and metabolism isorchestrated by reciprocal signalling between the
clock oscillator and metabolic pathways.”
Temporal restriction of metabolic functions may provide
advantages for organisms as they anticipate and synchronize
their physiology to the environment. It is therefore not entirely
surprising that disruptions of circadian timing have been asso-
ciated with diseases such as sleep disorders, cardiovascular
disease, metabolic syndrome and certain cancers [18–23]. In
the context of metabolic homeostasis, circadian misalignments
have been shown to elevate blood glucose and insulin concen-
trations in healthy individuals, accompanied by reduced circu-
lating leptin levels and increased arterial blood pressure [24,25].
Whole body insulin sensitivity and glucose tolerance were sig-
nificantly impaired following disruption of normal sleep cycles.
In mice, high-fat feeding directly impacts the body clock while
meal timing by restricted feeding profoundly alters the course
of diet-induced obesity and its associated metabolic disorders
[26]. The metabolic phenotype of several clock gene mutants
has been characterized. Clockmutantmice develop obesity and
display characteristics of metabolic syndrome [27], whereas
mice lacking Bmal1, a heterodimer partner for Clock, have
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impaired glucose homeostasis and develop accelerated age-
ing [28,29]. Pancreas-specific inactivation of Bmal1 markedly
impaired glucose-stimulated insulin secretion and resulted in
hyperglycaemia in mice [30,31]. Deficiency of both Rev-erb𝛼
and Rev-erb𝛽 resulted in elevated blood glucose and plasma
triglyceride levels and hepatic steatosis [32,33]. These obser-
vations show that different clock components exert distinct
and tissue-specific effects on energy metabolism, underscor-
ing the complex relationship between the molecular clock and
metabolic pathways.
Integration of Clock and Metabolism by the
PGC-1 Coactivators
The PPAR𝛾 coactivator 1 (PGC-1) family of transcriptional
coactivators includes PGC-1𝛼, PGC-1𝛽 and PGC-related
coactivator [34,35]. PGC-1𝛼 expression is highly inducible in
brown fat by cold exposure [36] in the liver following star-
vation [37,38] and in skeletal muscle in response to physical
exercise [39,40]. Hepatic PGC-1𝛽 expression is responsive to
dietary intake of saturated fats [41]. Inmany cell types, PGC-1𝛼
and PGC-1𝛽 stimulate the expression of mitochondrial gene
programmes encoded by both nuclear and mitochondrial
genomes. PGC-1𝛼 deficiency leads to impaired mitochondrial
oxidative metabolism in several tissues, including the brain,
heart, skeletal muscle, brown fat and the liver [42]. Similar
defects of mitochondrial gene expression and respiratory
function were also observed in PGC-1𝛽 null mouse tissues
[43], suggesting that they play non-redundant roles in main-
taining mitochondrial oxidative metabolism. A remarkable
feature of PGC-1 action is that they coordinate diverse aspects
of metabolic adaptation in tissues in response to nutritional
and hormonal cues. For example, mice lacking PGC-1𝛼
exhibited impaired cold-induced thermogenesis and exercise
endurance and had aberrant induction of hepatic starvation
response. Beyond mitochondrial metabolism, PGC-1 coac-
tivators also regulate diverse biological processes in a cell
type-specific manner. PGC-1𝛼 stimulates hepatic gluconeoge-
nesis [38] and oxidative muscle fibre formation [44], whereas
PGC-1𝛽 promotes lipoprotein secretion [41,45] and bone
homeostasis [46].
Previous studies have shown that the expression of PGC-1𝛼
and PGC-1𝛽 exhibits strong diurnal rhythms in the liver and
skeletal muscle [47,48]. PGC-1𝛼 induces the expression of
several core clock genes, particularly Bmal1, Clock, Per2 and
Rev-erb𝛼, in a cell-autonomous manner.The induction of clock
gene expression is at least in part mediated through its coac-
tivation of orphan nuclear receptor ROR𝛼 (Figure 1). The
PGC-1𝛼/ROR and Rev-erb𝛼/HDAC transcriptional complexes
appear to play an antagonistic role in the transcriptional reg-
ulation of Bmal1 expression [49,50]. The physiological role of
PGC-1𝛼 in normal clock function was supported by significant
impairments of diurnal rhythms of locomotor activity, body
temperature and metabolic rate in PGC-1𝛼 null mice. Simi-
larly, mice lacking PGC-1𝛽 also display abnormal diurnal loco-
motor activity patterns [51]. These results strongly implicate
the PGC-1 coactivators as a nodal point in integrating energy
metabolism and the body clock.
Figure 1. Integration of clock and hepatic metabolism by PGC-1𝛼.
PGC-1𝛼 coordinately regulates clock and metabolic gene expression
through coactivation of its transcriptional partners. PGC-1𝛼 is reciprocally
modulated by the biological clock through CK1𝛿-mediated phosphoryla-
tion. PGC-1, PPAR𝛾 coactivator 1; CK1𝛿, casein kinase 1𝛿.
Circadian Regulation of Hepatic
Gluconeogenesis by PGC-1𝜶
At themolecular level, the PGC-1 coactivators exert their effects
through physical interaction with transcription factors and
chromatin-remodelling complexes. Both PGC-1𝛼 and PGC-1𝛽
interact with nuclear respiratory factor 1 (NRF1), oestrogen
receptor-related receptor 𝛼 (ERR𝛼) and ERR𝛾 to regulate mito-
chondrial biogenesis [34,35].These coactivators recruit histone
acetyltransferase (HAT), the TRAP/DRIP/mediator complex,
the SIRT1 histone deacetylase complex and the SWI/SNF
chromatin-remodelling complexes to regulate the epigenetic
state of local chromatin [52–55]. At least two non-mutually
exclusive mechanisms are engaged by PGC-1𝛼 to regulate
rhythmic expression of genes involved in hepatic gluconeoge-
nesis: direct transcriptional regulation and indirect regulation
through ubiquitin-specific protease 2 (Usp2). Previous studies
have established hepatic nuclear factor 4𝛼 (HNF4𝛼), gluco-
corticoid receptor (GR) and forkhead box O1 (FoxO1) as
key mediators of gluconeogenic gene regulation by PGC-1𝛼
[38,56]. As such, it is probably that cyclic induction of PGC-1𝛼
leads to rhythmic activation of its transcriptional partners and
target gene expression.
“PGC-1 coactivators directly regulate the coreclock and metabolic gene programmes through
coactivating specific transcriptional partners.”
Alternatively, PGC-1𝛼 also regulates hepatic glucogenesis
indirectly through its induction of Usp2 [57,58]. The deu-
biquinating enzymes are a family of cysteine proteases that
catalyse the removal of ubiquitin from their target proteins.
These proteases deubiquitinate a wide array of substrate
proteins and regulate diverse biological processes, including
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vesicular trafficking, signal transduction, gene transcription
as well as metabolism. In primary hepatocytes, the expression
of Usp2 was strongly stimulated by PGC-1𝛼. Further, Usp2
expression exhibits strong diurnal rhythms in several tissues,
including the liver and skeletal muscle. It is notable that Usp2 is
the only ubiquitin-specific protease exhibiting significant cir-
cadian regulation. At the functional level, Usp2 is required for
the induction of gluconeogenic and fatty acid 𝛽-oxidation
genes by PGC-1𝛼 in hepatocytes. Adenoviral-mediated
expression of Usp2 in the liver increases hepatic glucose
production and exacerbates glucose intolerance in high-fat
diet-induced obese mice, whereas in vivo RNAi knockdown of
Usp2 improves systemic glycemic control. Importantly, hep-
atic rhythmic expression of Usp2 is required for maintaining
diurnal glucose regulation in response to restricted feeding.
Together, these studies delineate a novel pathway that links
hormonal and circadian signals to gluconeogenesis and glucose
homeostasis.
Posttranslational mechanisms also play an important role in
clock function [59–62]. In particular, casein kinase 1𝛿 (CK1𝛿)
and CK1𝜀 regulate the length of circadian period through
phosphorylating several clock proteins. Mutation of CK1𝜀 is
responsible for the tau mutant phenotype in Syrian hamsters,
which is characterized by shortened circadian period [63,64].
Interestingly, mutation of Doubletime, a Drosophila ortholog
of CK1𝜀, also results in altered period length [65–67]. A
missense mutation (T44A) of CK1𝛿 causes familial advanced
sleep-phase syndrome, which is characterized by early sleep
onset and early awakening in the morning [68]. Phospho-
rylation of clock proteins by CK1𝛿 regulates their stability,
subcellular localization and protein–protein interaction. In a
search for proteins associated with PGC-1𝛼, it was discovered
that both CK1𝛿 and CK1𝜀 physically interact with PGC-1𝛼
[69]. PGC-1𝛼 serves as a substrate of CK1 with phosphoryla-
tion sites mapped to a domain near the C-terminus of PGC-1𝛼.
CK1-mediated phosphorylation reduced PGC-1𝛼 protein
stability and transcriptional activity, resulting in impaired hor-
monal induction of gluconeogenic gene expression and glucose
output. These findings illustrate that the clock oscillator recip-
rocally signals to PGC-1𝛼 and its downstream metabolic gene
programmes through transcriptional and posttranslational
mechanisms.
Circadian Regulation of Autophagy
Autophagy is a conserved cellular process responsible for
turnover of long-lived proteins and organelles, and plays an
essential role in organismal adaptation to starvation [70,71].
Nutrient limitation initiates a cascade of vesicle nucleation,
autophagosome formation, docking and fusion with lysosome
and subsequent lysosomal degradation. Autophagy is markedly
induced in neonatal tissues and in adult tissues in response
to starvation [72,73]. Defects in autophagy result in lower
plasma glucose and amino acid concentrations during the
early postnatal period, leading to impaired adaptation and sur-
vival. In addition, autophagy is required for removing protein
aggregates, damaged organelles and certain pathogens [71].
Autophagy deficiency has been implicated in the pathogenesis
of several disease conditions, such as cancer, diabetes, hepatic
steatosis, skeletal myopathy and neurodegeneration [74].
Electron microscopy studies performed in the 1970s showed
that the number of autophagic vacuoles varies throughout the
day in several cell types, including the inner segment of retina
rod cells, cardiomyocytes, hepatocytes, pancreatic acinar cells
and proximal tubules of kidney in rats [75,76]. Using a com-
bination of autophagy markers and flux measurements, recent
studies indicated that autophagy activity exhibits a robust
diurnal rhythm in the liver, heart and skeletal muscle [77,78].
Autophagy flux can be estimated by measuring the degrada-
tion rate of microtubule-associated protein1 light chain 3-II
(LC3-II), a marker for autophagy induction.This measurement
revealed that autophagy flux in the liver reached a peak in
the afternoon and decreased to lower levels in the dark phase.
Importantly, the cyclic activation of autophagy flux in the liver
is associated with rhythmic expression of autophagy genes [78].
The physiological significance of autophagy cycles remains
unknown. It is possible that close coupling of autophagic
protein degradation to the body clock may provide unique
advantages for mammals to maintain systemic nutrient and
energy homeostasis. Further, time-dependent remodelling
of cellular proteomes and organelles may be fundamentally
important for metabolic homeostasis along the temporal
axis. The latter potentially serves an important function in
restricting cellular metabolic functions to specific time periods
during LD cycles.
Transcriptional regulation of autophagy genes has emerged
as an importantmechanism in autophagy. Several transcription
factors have been identified that regulate various aspects of the
autophagy gene programme, including Forkhead transcription
factor O3 (FoxO3) and transcription factor EB (TFEB). FoxO3
was identified as a regulator of autophagy in skeletal myocytes
by stimulating the expression of autophagy genes, including
LC3B, Gabarapl1, Bnip3 and Bnip3l [79]. TFEB induces the
expression of a large number of genes involved in lysosome
biogenesis, autophagy and lysosomal exocytosis [80,81]. TFEB
is colocalized with mTORC1 under normal growth conditions
and undergoes nuclear translocation in response to starva-
tion and lysosomal stress [82,83]. In the context of circadian
autophagy, CCAAT/enhancer binding protein 𝛽 (C/EBP𝛽)
is emerging as a key regulator of rhythmic autophagy gene
expression in the liver [78]. C/EBP𝛽 is a basic leucine zipper
transcription factor that regulates diverse biological processes.
The expression of C/EBP𝛽 itself is highly rhythmic and is
dependent on the liver clock. Gain-of-function studies using
adenoviral-mediated gene expression indicated that C/EBP𝛽
promotes the programme of autophagy gene expression and
induces autophagic protein degradation in cultured hepato-
cytes. C/EBP𝛽 directly binds to the promoters of autophagy
genes and activates their transcription [78]. C/EBP𝛽 itself is
a target of core clock and is required for the regulation of
rhythmic autophagy in the liver.
“Circadian control of autophagy rhythm ismediated by transcriptional control of autophagy
gene expression by C/EBP𝛽 and PGC-1𝛽.”
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PGC-1𝜷 and Rhythmic Autophagy Regulation
The physiological role of PGC-1 coactivators in transcrip-
tional regulation of autophagy genes has not been established.
In co-immunoprecipitation (co-IP) studies, PGC-1𝛽 was
found to be physically associated with C/EBP𝛽 in transiently
transfected 293T cells (Figure 2A), suggesting that it may func-
tion as a transcriptional coactivator for C/EBP𝛽. Importantly,
adenoviral-mediated overexpression of PGC-1𝛽 stimulated
the expression of many C/EBP𝛽-regulated autophagy genes
in primary hepatocytes, including FIP200, Ulk1, LC3B, Atg2a,
Gabarapl1, Bnip3, Atg16l1 and Atp6v0a2, a subunit of vacuolar
proton pump (Figure 2B). PGC-1𝛽 also stimulates the expres-
sion of C/EBP𝛽, suggesting that these two factors may form a
feed-forward regulatory loop. Recent studies have shown that
the mammalian Ulk1-FIP200-Atg13 kinase complex, which
is equivalent to the Atg1 complex in yeast, integrates diverse
nutrient signals and controls the initiation of autophagy in
the cell [84,85]. Liver-specific inactivation of FIP200 severely
impaired autophagy in hepatocytes and resulted in liver injury
[86]. As such, FIP200 and Ulk1 may provide an important link
between PGC-1𝛽 and the autophagy pathway.
Activation of autophagy enhances the degradation of
sequestosome 1 (p62), an LC3-interacting protein that delivers
cargos for lysosomal degradation. Consistently, we found that
PGC-1𝛽 significantly reduces steady-state p62 levels in trans-
duced hepatocytes (Figure 2C). Similar effects on p62 levels
were also observed in the livers from mice transduced with
PGC-1𝛽 adenovirus (Figure 2D). Together, these studies show
that PGC-1𝛽may serve as a coactivator for C/EBP𝛽 to stimulate
autophagy gene expression and enhance autophagy activity. As
the expression of PGC-1𝛽 exhibits diurnal rhythms in the liver,
it is likely that the rhythmic induction of C/EBP𝛽 and PGC-1𝛽
may mediate circadian signalling to drive rhythmic activation
of autophagy.
Perspectives
Circadian metabolic rhythms are a core feature of mam-
malian nutrient and energy homeostasis and have important
implications in health and disease. The mechanisms that
integrate metabolic functions with circadian timing in tis-
sue are complex and probably involve reciprocal crosstalk
between the metabolic regulatory networks and the biological
clock. The molecular clock directly regulates the expression
of downstream metabolic genes and participates in driv-
ing diurnal metabolic cycles. In parallel, the clock oscillator
also responds to nutritional and hormonal cues by adjusting
the phase and/or amplitude of rhythmic gene expression.
Consequently, while the regulatory circuits are somewhat
hardwired between the clockwork and the metabolic gene
programmes, remarkable flexibility exists to allow fine-tuning
of metabolic output from tissues. The ebb-and-flow of tissue
metabolism is emerging to represent unique opportunities for
therapeutic intervention by restoring the rhythmicity of the















































Figure 2. Induction of autophagy by the C/EBP𝛽/PGC-1𝛽 transcriptional complex. (A) Physical interaction between PGC-1𝛽 and C/EBP𝛽. (B) qPCR
analysis of hepatocytes transduced with green fluorescence protein (GFP) (open) or PGC-1𝛽 (filled) adenovirus. Shown is mean± standard deviation of
one representative experiment in triplicates, *p< 0.01. (C) Immunoblots of total lysates from hepatocytes transduced with GFP or PGC-1𝛽 adenovirus. (D)
Immunoblots of pooled lysates from transduced livers obtained in two independent experiments. C/EBP𝛽, CCAAT/enhancer binding protein 𝛽; PGC-1,
PPAR𝛾 coactivator 1; qPCR, quantitative polymerase-chain-reaction.
36 Li and Lin Volume 17 Suppl. 1 September 2015
DIABETES, OBESITY AND METABOLISM review article
Acknowledgements
The authors would like to thank other members of the labora-
tory for discussions. This work was supported by the National
Institutes of Health (DK077086 and DK095151). The authors
apologize to colleagues whose relevant work was not cited here
because of space limitation.
Conflict of Interest
The authors declare no conflict of interest.
References
1. Damiola F, Le Minh N, Preitner N, Kornmann B, Fleury-Olela F, Schibler U.
Restricted feeding uncouples circadian oscillators in peripheral tissues from
the central pacemaker in the suprachiasmatic nucleus. Genes Dev 2000; 14:
2950–2961.
2. Hara R, Wan K, Wakamatsu H et al. Restricted feeding entrains liver clock
without participation of the suprachiasmatic nucleus. Genes Cells 2001; 6:
269–278.
3. Stokkan KA, Yamazaki S, Tei H, Sakaki Y, Menaker M. Entrainment of the
circadian clock in the liver by feeding. Science 2001; 291: 490–493.
4. Geusz ME, Fletcher C, Block GD et al. Long-term monitoring of circadian
rhythms in c-fos gene expression from suprachiasmatic nucleus cultures. Curr
Biol 1997; 7: 758–766.
5. Balsalobre A, Damiola F, Schibler U. A serum shock induces circadian gene
expression in mammalian tissue culture cells. Cell 1998; 93: 929–937.
6. Nagoshi E, Saini C, Bauer C, Laroche T, Naef F, Schibler U. Circadian gene expres-
sion in individual fibroblasts: cell-autonomous and self-sustained oscillators
pass time to daughter cells. Cell 2004; 119: 693–705.
7. Asher G, Sassone-Corsi P. Time for food: the intimate interplay between
nutrition, metabolism, and the circadian clock. Cell 2015; 161: 84–92.
8. Asher G, Schibler U. Crosstalk between components of circadian and metabolic
cycles in mammals. Cell Metab 2011; 13: 125–137.
9. Bass J, Takahashi JS. Circadian integration of metabolism and energetics.
Science 2010; 330: 1349–1354.
10. Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA. The human circadian
metabolome. Proc Natl Acad Sci U S A 2012; 109: 2625–2629.
11. Eckel-Mahan KL, Patel VR, Mohney RP, Vignola KS, Baldi P, Sassone-Corsi P.
Coordination of the transcriptome and metabolome by the circadian clock. Proc
Natl Acad Sci U S A 2012; 109: 5541–5546.
12. Kasukawa T, Sugimoto M, Hida A et al. Human blood metabolite timetable
indicates internal body time. Proc Natl Acad Sci U S A 2012; 109: 15036–15041.
13. Lowrey PL, Takahashi JS. Mammalian circadian biology: elucidating
genome-wide levels of temporal organization. Annu Rev Genomics Hum
Genet 2004; 5: 407–441.
14. Panda S, Antoch MP, Miller BH et al. Coordinated transcription of key pathways
in the mouse by the circadian clock. Cell 2002; 109: 307–320.
15. Storch KF, Lipan O, Leykin I et al. Extensive and divergent circadian gene
expression in liver and heart. Nature 2002; 417: 78–83.
16. Ueda HR, Chen W, Adachi A et al. A transcription factor response element for
gene expression during circadian night. Nature 2002; 418: 534–539.
17. Zhang R, Lahens NF, Ballance HI, Hughes ME, Hogenesch JB. A circadian gene
expression atlas in mammals: implications for biology and medicine. Proc Natl
Acad Sci U S A 2014; 111: 16219–16224.
18. Copinschi G, Spiegel K, Leproult R, Van Cauter E. Pathophysiology of human
circadian rhythms. Novartis Found Symp 2000; 227: 143–157; discussion
157–162..
19. Cutolo M, Otsa K, Aakre O, Sulli A. Nocturnal hormones and clinical rhythms in
rheumatoid arthritis. Ann N Y Acad Sci 2005; 1051: 372–381.
20. Czeisler CA, Klerman EB. Circadian and sleep-dependent regulation of hormone
release in humans. Recent Prog Horm Res 1999; 54: 97–130; discussion
130–132.
21. Fu L, Lee CC. The circadian clock: pacemaker and tumour suppressor. Nat Rev
Cancer 2003; 3: 350–361.
22. Jones CR, Campbell SS, Zone SE et al. Familial advanced sleep-phase syn-
drome: a short-period circadian rhythm variant in humans. Nat Med 1999; 5:
1062–1065.
23. Klerman GL, Davidson EM, Kayce MM. Factors influencing the clinical responses
of schizophrenic patients to phenothiazine drugs and to placebo. Psychiatr Res
Rep Am Psychiatr Assoc 1964; 19: 97–115.
24. Scheer FA, Hilton MF, Mantzoros CS, Shea SA. Adverse metabolic and cardiovas-
cular consequences of circadian misalignment. Proc Natl Acad Sci U S A 2009;
106: 4453–4458.
25. Spiegel K, Tasali E, Leproult R, Van Cauter E. Effects of poor and short sleep on
glucose metabolism and obesity risk. Nat Rev Endocrinol 2009; 5: 253–261.
26. Hatori M, Vollmers C, Zarrinpar A et al. Time-restricted feedingwithout reducing
caloric intake preventsmetabolic diseases inmice fed a high-fat diet. Cell Metab
2012; 15: 848–860.
27. Turek FW, Joshu C, Kohsaka A et al. Obesity andmetabolic syndrome in circadian
Clock mutant mice. Science 2005; 308: 1043–1045.
28. Lamia KA, Storch KF, Weitz CJ. Physiological significance of a peripheral tissue
circadian clock. Proc Natl Acad Sci U S A 2008; 105: 15172–15177.
29. Rudic RD, McNamara P, Curtis AM et al. BMAL1 and CLOCK, two essential
components of the circadian clock, are involved in glucose homeostasis. PLoS
Biol 2004; 2: e377.
30. Lee J, Kim MS, Li R et al. Loss of Bmal1 leads to uncoupling and impaired
glucose-stimulated insulin secretion in beta-cells. Islets 2011; 3: 381–388.
31. Marcheva B, Ramsey KM, Buhr ED et al. Disruption of the clock components
CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature 2010; 466:
627–631.
32. Bugge A, Feng D, Everett LJ et al. Rev-erbalpha and Rev-erbbeta coordinately
protect the circadian clock and normal metabolic function. Genes Dev 2012;
26: 657–667.
33. Cho H, Zhao X, Hatori M et al. Regulation of circadian behaviour and
metabolism by REV-ERB-alpha and REV-ERB-beta. Nature 2012; 485:
123–127.
34. Lin J, Handschin C, Spiegelman BM.Metabolic control through the PGC-1 family
of transcription coactivators. Cell Metab 2005; 1: 361–370.
35. Scarpulla RC, Vega RB, Kelly DP. Transcriptional integration of mitochondrial
biogenesis. Trends Endocrinol Metab 2012; 23: 459–466.
36. Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM. A
cold-inducible coactivator of nuclear receptors linked to adaptive thermoge-
nesis. Cell 1998; 92: 829–839.
37. Herzig S, Long F, Jhala US et al. CREB regulates hepatic gluconeogenesis
through the coactivator PGC-1. Nature 2001; 413: 179–183.
38. Yoon JC, Puigserver P, Chen G et al. Control of hepatic gluconeogenesis through
the transcriptional coactivator PGC-1. Nature 2001; 413: 131–138.
39. Baar K, Wende AR, Jones TE et al. Adaptations of skeletal muscle to exercise:
rapid increase in the transcriptional coactivator PGC-1. FASEB J 2002; 16:
1879–1886.
40. Terada S, Goto M, Kato M, Kawanaka K, Shimokawa T, Tabata I. Effects
of low-intensity prolonged exercise on PGC-1 mRNA expression in rat
epitrochlearis muscle. Biochem Biophys Res Commun 2002; 296: 350–354.
41. Lin J, Yang R, Tarr PT et al. Hyperlipidemic effects of dietary saturated fats
mediated through PGC-1beta coactivation of SREBP. Cell 2005; 120: 261–273.
Volume 17 Suppl. 1 September 2015 doi:10.1111/dom.12520 37
review article DIABETES, OBESITY AND METABOLISM
42. Lin J, Wu PH, Tarr PT et al. Defects in adaptive energy metabolism with
CNS-linked hyperactivity in PGC-1alpha null mice. Cell 2004; 119: 121–135.
43. Lelliott CJ, Medina-Gomez G, Petrovic N et al. Ablation of PGC-1beta results in
defective mitochondrial activity, thermogenesis, hepatic function, and cardiac
performance. PLoS Biol 2006; 4: e369.
44. Lin J, Wu H, Tarr PT et al. Transcriptional co-activator PGC-1 alpha drives the
formation of slow-twitch muscle fibres. Nature 2002; 418: 797–801.
45. Hernandez C, Molusky M, Li Y, Li S, Lin JD. Regulation of hepatic ApoC3
expression by PGC-1beta mediates hypolipidemic effect of nicotinic acid. Cell
Metab 2010; 12: 411–419.
46. Ishii KA, Fumoto T, Iwai K et al. Coordination of PGC-1beta and iron uptake
in mitochondrial biogenesis and osteoclast activation. Nat Med 2009; 15:
259–266.
47. Lin JD, Liu C, Li S. Integration of energy metabolism and the mammalian clock.
Cell Cycle 2008; 7: 453–457.
48. Liu C, Li S, Liu T, Borjigin J, Lin JD. Transcriptional coactivator PGC-1alpha
integrates the mammalian clock and energy metabolism. Nature 2007; 447:
477–481.
49. Alenghat T, Meyers K, Mullican SE et al. Nuclear receptor corepressor and
histone deacetylase 3 govern circadian metabolic physiology. Nature 2008;
456: 997–1000.
50. Yin L, Lazar MA. The orphan nuclear receptor Rev-erbalpha recruits the
N-CoR/histone deacetylase 3 corepressor to regulate the circadian Bmal1 gene.
Mol Endocrinol 2005; 19: 1452–1459.
51. Sonoda J, Mehl IR, Chong LW, Nofsinger RR, Evans RM. PGC-1beta controls
mitochondrial metabolism to modulate circadian activity, adaptive thermoge-
nesis, and hepatic steatosis. Proc Natl Acad Sci U S A 2007; 104: 5223–5228.
52. Puigserver P, Adelmant G, Wu Z et al. Activation of PPARgamma coactivator-1
through transcription factor docking. Science 1999; 286: 1368–1371.
53. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. Nutrient
control of glucose homeostasis through a complex of PGC-1alpha and SIRT1.
Nature 2005; 434: 113–118.
54. Wallberg AE, Yamamura S, Malik S, Spiegelman BM, Roeder RG. Coordination
of p300-mediated chromatin remodeling and TRAP/mediator function through
coactivator PGC-1alpha. Mol Cell 2003; 12: 1137–1149.
55. Li S, Liu C, Li N et al. Genome-wide coactivation analysis of PGC-1alpha
identifies BAF60a as a regulator of hepatic lipid metabolism. Cell Metab 2008;
8: 105–117.
56. Puigserver P, Rhee J, Donovan J et al. Insulin-regulated hepatic gluconeogenesis
through FOXO1-PGC-1alpha interaction. Nature 2003; 423: 550–555.
57. Molusky MM, Li S, Ma D, Yu L, Lin JD. Ubiquitin-specific protease 2 reg-
ulates hepatic gluconeogenesis and diurnal glucose metabolism through
11beta-hydroxysteroid dehydrogenase 1. Diabetes 2012; 61: 1025–1035.
58. Molusky MM, Ma D, Buelow K, Yin L, Lin JD. Peroxisomal localization and
circadian regulation of ubiquitin-specific protease 2. PLoS One 2012; 7: e47970.
59. Reppert SM, Weaver DR. Molecular analysis of mammalian circadian rhythms.
Annu Rev Physiol 2001; 63: 647–676.
60. Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature
2002; 418: 935–941.
61. Loudon AS, Meng QJ, Maywood ES, Bechtold DA, Boot-Handford RP, Hastings
MH. The biology of the circadian Ck1 epsilon tau mutation in mice and Syrian
hamsters: a tale of two species. Cold Spring Harb Symp Quant Biol 2007; 72:
261–271.
62. Virshup DM, Eide EJ, Forger DB, Gallego M, Harnish EV. Reversible protein
phosphorylation regulates circadian rhythms. Cold Spring Harb Symp Quant
Biol 2007; 72: 413–420.
63. Lowrey PL, Shimomura K, Antoch MP et al. Positional syntenic cloning and
functional characterization of the mammalian circadian mutation tau. Science
2000; 288: 483–492.
64. Ralph MR, Menaker M. A mutation of the circadian system in golden hamsters.
Science 1988; 241: 1225–1227.
65. Kloss B, Price JL, Saez L et al. The Drosophila clock gene double-time encodes
a protein closely related to human casein kinase I epsilon. Cell 1998; 94:
97–107.
66. Price JL, Blau J, Rothenfluh A, Abodeely M, Kloss B, Young MW. Double-time is a
novel Drosophila clock gene that regulates PERIOD protein accumulation. Cell
1998; 94: 83–95.
67. Young MW. The molecular control of circadian behavioral rhythms and their
entrainment in Drosophila. Annu Rev Biochem 1998; 67: 135–152.
68. Xu Y, Padiath QS, Shapiro RE et al. Functional consequences of a CKI delta
mutation causing familial advanced sleep phase syndrome. Nature 2005; 434:
640–644.
69. Li S, Chen XW, Yu L, Saltiel AR, Lin JD. Circadian metabolic regulation
through crosstalk between casein kinase 1 delta and transcriptional coactivator
PGC-1alpha. Mol Endocrinol 2011; 25: 2084–2093.
70. He C, Klionsky DJ. Regulation mechanisms and signaling pathways of
autophagy. Annu Rev Genet 2009; 43: 67–93.
71. Mizushima N, KomatsuM. Autophagy: renovation of cells and tissues. Cell 2011;
147: 728–741.
72. Kuma A, Hatano M, Matsui M et al. The role of autophagy during the early
neonatal starvation period. Nature 2004; 432: 1032–1036.
73. Mizushima N, Yamamoto A, Matsui M, Yoshimori T, Ohsumi Y. In vivo anal-
ysis of autophagy in response to nutrient starvation using transgenic mice
expressing a fluorescent autophagosome marker. Mol Biol Cell 2004; 15:
1101–1111.
74. Choi AM, Ryter SW, Levine B. Autophagy in human health and disease. N Engl
J Med 2013; 368: 651–662.
75. Pfeifer U, Strauss P. Autophagic vacuoles in heart muscle and liver. A compara-
tive morphometric study including circadian variations in meal-fed rats. J Mol
Cell Cardiol 1981; 13: 37–49.
76. Pfeifer U, Scheller H. A morphometric study of cellular autophagy including
diurnal variations in kidney tubules of normal rats. J Cell Biol 1975; 64:
608–621.
77. Ma D, Li S, Molusky MM, Lin JD. Circadian autophagy rhythm: a link between
clock and metabolism? Trends Endocrinol Metab 2012; 23: 319–325.
78. Ma D, Panda S, Lin JD. Temporal orchestration of circadian autophagy rhythm
by C/EBPbeta. EMBO J 2011; 30: 4642–4651.
79. Mammucari C, Milan G, Romanello V et al. FoxO3 controls autophagy in skeletal
muscle in vivo. Cell Metab 2007; 6: 458–471.
80. Settembre C, Di Malta C, Polito VA et al. TFEB links autophagy to lysosomal
biogenesis. Science 2011; 332: 1429–1433.
81. Sardiello M, Palmieri M, di Ronza A et al. A gene network regulating lysosomal
biogenesis and function. Science 2009; 325: 473–477.
82. Pena-Llopis S, Vega-Rubin-de-Celis S, Schwartz JC et al. Regulation of TFEB and
V-ATPases by mTORC1. EMBO J 2011; 30: 3242–3258.
83. Settembre C, Zoncu R, Medina DL et al. A lysosome-to-nucleus signalling
mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J
2012; 31: 1095–1108.
84. Hosokawa N, Hara T, Kaizuka T et al. Nutrient-dependent mTORC1 association
with the ULK1-Atg13-FIP200 complex required for autophagy. Mol Biol Cell
2009; 20: 1981–1991.
85. Jung CH, Jun CB, Ro SH et al. ULK-Atg13-FIP200 complexes mediate
mTOR signaling to the autophagy machinery. Mol Biol Cell 2009; 20:
1992–2003.
86. Ma D, Molusky MM, Song J et al. Autophagy deficiency by hepatic FIP200
deletion uncouples steatosis from liver injury in NAFLD. Mol Endocrinol 2013;
27: 1643–1654.
38 Li and Lin Volume 17 Suppl. 1 September 2015
